Prime Medicine Inc (PRME)
7.085
+0.04
(+0.64%)
USD |
NASDAQ |
May 17, 16:00
7.085
0.00 (0.00%)
After-Hours: 20:00
Prime Medicine Total Long Term Debt (Quarterly): 0.00 for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2024
--
Maximum
Mar 2024
--
Average
--
Median
Mar 2024
Total Long Term Debt (Quarterly) Benchmarks
Pacific Biosciences of California Inc | 892.54M |
10x Genomics Inc | 0.00 |
Recursion Pharmaceuticals Inc | 1.126M |
Verve Therapeutics Inc | 0.00 |
Ginkgo Bioworks Holdings Inc | 0.00 |